Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Statistics

Total Valuation

AQST has a market cap or net worth of $282.65 million. The enterprise value is $241.63 million.

Market Cap	282.65M
Enterprise Value	241.63M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, after market close.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

AQST has 91.18 million shares outstanding. The number of shares has increased by 39.07% in one year.

Current Share Class	91.18M
Shares Outstanding	91.18M
Shares Change (YoY)	+39.07%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	5.09%
Owned by Institutions (%)	48.73%
Float	80.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.25
Forward PS	5.24
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.37

Current Ratio	6.37
Quick Ratio	5.78
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.33

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-15.57%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$436,296
Profits Per Employee	-$260,689
Employee Count	135
Asset Turnover	0.70
Inventory Turnover	2.56

Taxes

In the past 12 months, AQST has paid $101,000 in taxes.

Income Tax	101,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.76% in the last 52 weeks. The beta is 2.71, so AQST's price volatility has been higher than the market average.

Beta (5Y)	2.71
52-Week Price Change	+16.76%
50-Day Moving Average	4.07
200-Day Moving Average	3.91
Relative Strength Index (RSI)	34.77
Average Volume (20 Days)	1,545,430

Short Selling Information

The latest short interest is 10.48 million, so 11.50% of the outstanding shares have been sold short.

Short Interest	10.48M
Short Previous Month	9.65M
Short % of Shares Out	11.50%
Short % of Float	12.95%
Short Ratio (days to cover)	6.51

Income Statement

In the last 12 months, AQST had revenue of $58.90 million and -$35.19 million in losses. Loss per share was -$0.44.

Revenue	58.90M
Gross Profit	40.87M
Operating Income	-21.10M
Pretax Income	-25.76M
Net Income	-35.19M
EBITDA	-20.04M
EBIT	-21.10M
Loss Per Share	-$0.44

Balance Sheet

The company has $77.89 million in cash and $36.87 million in debt, giving a net cash position of $41.02 million or $0.45 per share.

Cash & Cash Equivalents	77.89M
Total Debt	36.87M
Net Cash	41.02M
Net Cash Per Share	$0.45
Equity (Book Value)	-45.42M
Book Value Per Share	-0.50
Working Capital	81.42M

Cash Flow

In the last 12 months, operating cash flow was -$34.21 million and capital expenditures -$160,000, giving a free cash flow of -$34.37 million.

Operating Cash Flow	-34.21M
Capital Expenditures	-160,000
Free Cash Flow	-34.37M
FCF Per Share	-$0.38

Margins

Gross margin is 69.39%, with operating and profit margins of -35.83% and -59.75%.

Gross Margin	69.39%
Operating Margin	-35.83%
Pretax Margin	-59.58%
Profit Margin	-59.75%
EBITDA Margin	-34.02%
EBIT Margin	-35.83%
FCF Margin	n/a

Dividends & Yields

AQST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.07%
Shareholder Yield	-39.07%
Earnings Yield	-12.45%
FCF Yield	-12.16%

Analyst Forecast

The average price target for AQST is $10.38, which is 234.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.38
Price Target Difference	234.84%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	33.19%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AQST has an Altman Z-Score of -2.64 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.64
Piotroski F-Score	4